- Home
- LAB vs NMAI Comparison
LAB vs NMAI Comparison
Compare LAB & NMAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAB
- NMAI
- Stock Information
- Founded
- LAB 1999
- NMAI 2021
- Country
- LAB United States
- NMAI United States
- Employees
- LAB N/A
- NMAI N/A
- Industry
- LAB Biotechnology: Laboratory Analytical Instruments
- NMAI Investment Managers
- Sector
- LAB Industrials
- NMAI Finance
- Exchange
- LAB Nasdaq
- NMAI Nasdaq
- Market Cap
- LAB 372.1M
- NMAI 422.8M
- IPO Year
- LAB 2011
- NMAI N/A
- Fundamental
- Price
- LAB $1.34
- NMAI $12.64
- Analyst Decision
- LAB Buy
- NMAI
- Analyst Count
- LAB 2
- NMAI 0
- Target Price
- LAB $2.50
- NMAI N/A
- AVG Volume (30 Days)
- LAB 2.8M
- NMAI 74.8K
- Earning Date
- LAB 07-30-2025
- NMAI 01-01-0001
- Dividend Yield
- LAB N/A
- NMAI 13.14%
- EPS Growth
- LAB N/A
- NMAI N/A
- EPS
- LAB N/A
- NMAI 0.64
- Revenue
- LAB $169,687,000.00
- NMAI N/A
- Revenue This Year
- LAB N/A
- NMAI N/A
- Revenue Next Year
- LAB $12.18
- NMAI N/A
- P/E Ratio
- LAB N/A
- NMAI $19.03
- Revenue Growth
- LAB 33.86
- NMAI N/A
- 52 Week Low
- LAB $0.92
- NMAI $10.60
- 52 Week High
- LAB $2.41
- NMAI $12.55
- Technical
- Relative Strength Index (RSI)
- LAB 58.76
- NMAI 58.32
- Support Level
- LAB $1.27
- NMAI $12.54
- Resistance Level
- LAB $1.41
- NMAI $12.73
- Average True Range (ATR)
- LAB 0.11
- NMAI 0.11
- MACD
- LAB 0.01
- NMAI 0.00
- Stochastic Oscillator
- LAB 50.00
- NMAI 73.86
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
About NMAI Nuveen Multi-Asset Income Fund of Beneficial Interest
Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment strategy uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund may invest in equity and debt securities of any type without limit.